Tetrahydroquinoline derivatives

US8110583B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Wolfgang Staehle · Ingelheim am Rhein, DE
• David Bruge · Frankfurt am Main, DE
• Kai Schiemann · Darmstadt, DE
• Dirk Finsinger · Darmstadt, DE
• Hans-Peter Buchstaller · Griesheim, DE
• Frank Zenke · Darmstadt, DE
• Christiane Amendt · Mühltal, DE

Key dates

• Filing date: May 31, 2006
• Grant date: Feb 7, 2012
• Expiry date: May 24, 2029

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D221/16
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds of the formula I, in which s, k, I, W, R1, R2, R3, and U have the meanings indicated in claim 1, can be employed, inter alia, for the treatment of tumours.